A currency trader works near a screen showing the Korea Composite Stock Price Index (KOSPI), left, and the foreign exchange ...

Shares of Hims and Hers Health (NYSE:HIMS) slid 14% in premarket trading following the telehealth company’s announcement of ...

Investors can buy Netflix, Inc. (NFLX) stock roughly 15% below its all-time highs and at some of its most oversold RSI levels ...

Meta Platforms could be a $4.7 trillion company in five years, in which case it would be worth more than Palantir and Nvidia combined today.

Both companies are likely to continue climbing, according to the Wall Street analysts who follow them. Recent price targets for both of these stocks suggest they can climb by 15% and 20%, respectively ...

Has the world's No. 3 cryptocurrency by market value -- up nearly 700% over the trailing-three-year period -- come too far, ...

If financial conditions are restrictive, Wall Street sure hasn’t noticed. Stock indexes hit fresh records this week, and speculative meme stocks are back to mania levels. Meanwhile, smaller businesses ...

Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But ...

The big question on most investors' minds is whether it makes more sense to buy dips or sell rips (rallies) following the drop. Veteran analyst Tom Lee, Fundstrat's founder and head of research, ...

Stocks surged Monday, led by tech sector gains, as the market recovered from a steep decline at the end of last week that was sparked by renewed concerns about tariffs and the health of the economy.

Powered by rising margins, global growth, and confidence from management, this sleep tech stock is turning heads again. The post ResMed share price is on watch for all-time highs appeared first on The ...

Australian shares may have largely shrugged off Wall Street’s nosedive yesterday, but now that U.S. indexes are surging back into the green, it looks like the ASX 200 is fairly happy to play follow ...